会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • APPARATUS AND METHOD FOR VENDING SECURELY STORED PRODUCTS TO CONSUMERS
    • 用于向消费者发放安全存储产品的装置和方法
    • US20120125060A1
    • 2012-05-24
    • US13291500
    • 2011-11-08
    • Michael GalloSteve Sanelli
    • Michael GalloSteve Sanelli
    • E05B35/00F16B1/00
    • E05B15/0046E05B13/004E05B15/101E05B35/12E05B47/023E05C3/24G07F7/0609Y10S70/62Y10S70/63Y10T70/625Y10T70/7441Y10T70/7768Y10T292/1047Y10T292/1062Y10T292/1078Y10T403/602
    • A lock mechanism is disclosed, the lock mechanism having a rotary latch configured for rotation between a locked position and an unlocked position, the rotary latch rotating in a first plane and the rotary latch is retained in the locked position after it has been rotated into the locked position from the unlocked position, the rotary latch being spring biased into the unlocked position by a biasing member; and a first lock mechanism for retaining the rotary latch in the locked position after rotation of the rotary latch into the locked position, the rotary latch being capable of being manipulated back into the unlocked position from the locked position after actuation of the first locking mechanism into a release position, wherein actuation of the first lock mechanism is in a second plane that is not parallel to the first plane and wherein the first lock mechanism must be reset in order to subsequently release the rotary latch from the locked position.
    • 公开了一种锁定机构,该锁定机构具有构造成在锁定位置和解锁位置之间旋转的旋转闩锁,所述旋转闩锁在第一平面中旋转,并且所述旋转闩锁在已经旋转到所述锁定位置之后被保持在所述锁定位置 锁定位置从解锁位置,旋转闩锁通过偏置构件弹簧偏置到解锁位置; 以及第一锁定机构,用于在将旋转闩锁旋转到锁定位置之后将旋转闩锁保持在锁定位置,所述旋转闩锁能够在致动第一锁定机构之后被从锁定位置操作回到解锁位置,进入 释放位置,其中所述第一锁定机构的致动处于不平行于所述第一平面的第二平面中,并且其中所述第一锁定机构必须被复位,以便随后将所述旋转闩锁从所述锁定位置释放。
    • 8. 发明申请
    • Human monoclonal antibodies to epidermal growth factor receptor
    • 人表皮生长因子受体单克隆抗体
    • US20050100546A1
    • 2005-05-12
    • US11021795
    • 2004-12-22
    • Aya JakobovitsXiao-Dong YangMichael GalloXiao-Chi Jia
    • Aya JakobovitsXiao-Dong YangMichael GalloXiao-Chi Jia
    • A61K38/00C07K16/28A61K39/395
    • C07K16/2863A61K38/00A61K2039/505C07K2317/21C07K2317/73C07K2317/77
    • In accordance with the present invention, there are provided fully human monoclonal antibodies against human epidermal growth factor receptor (EGF-r). Nucelotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences from CDR1 through CDR3, are provided. Hybridomas expressing such immunoglobulin molecules and monoclonal antibodies are also provided. Also provided in accordance with the invention are antibodies that possess one or more of the following functional characteristics: (i) inhibit tyrosine phosphorylation of EGF-r, (ii) do not inhibit EGF-r internalization, (ii) inhibit EGF-r degradation, (iii) inhibition of EGF induced EGF-r degradation, (iv) protect threonine phosphorylation of EGF-r, (v) protect threonine phosphorylation of other molecules, particularly a 62 KD molecule identified by immunoprecipitation, and (vi) inhibit vascular endothelial cell growth factor signal by tumor cells by greater than 50% and endothelial cells by greater than 40% relative to control.
    • 根据本发明,提供了针对人表皮生长因子受体(EGF-r)的完全人单克隆抗体。 提供了含有重链和轻链免疫球蛋白分子的Nuclotide序列编码和氨基酸序列,特别是对应于CDR1至CDR3的连续重链和轻链序列的序列。 还提供了表达这种免疫球蛋白分子和单克隆抗体的杂交瘤。 根据本发明还提供了具有一个或多个以下功能特征的抗体:(i)抑制EGF-r的酪氨酸磷酸化,(ii)不抑制EGF-r内化,(ii)抑制EGF-r降解 ,(iii)抑制EGF诱导的EGF-r降解,(iv)保护EGF-r的苏氨酸磷酸化,(v)保护其他分子,特别是通过免疫沉淀鉴定的62KD分子的苏氨酸磷酸化,和(vi)抑制血管内皮 肿瘤细胞的细胞生长因子信号大于50%,内皮细胞相对于对照组大于40%。